Correlation Between Mersana Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mersana Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mersana Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mersana Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Mersana Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mersana Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mersana Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Mersana Therapeutics and Aerovate Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mersana and Aerovate is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Mersana Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Mersana Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mersana Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Mersana Therapeutics i.e., Mersana Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Mersana Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Mersana Therapeutics is expected to under-perform the Aerovate Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Mersana Therapeutics is 1.35 times less risky than Aerovate Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Aerovate Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,931 in Aerovate Therapeutics on August 28, 2024 and sell it today you would lose (1,663) from holding Aerovate Therapeutics or give up 86.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mersana Therapeutics vs. Aerovate Therapeutics
Performance |
| Timeline |
| Mersana Therapeutics |
| Aerovate Therapeutics |
Mersana Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mersana Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Mersana Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mersana Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
| Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. Scpharmaceuticals | Aerovate Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |